This browser is no longer supported.
To provide you with the best possible experience, we kindly ask you to switch to a supported browser:
Are you a Healthcare Professional? Visit our Healthcare Professional Site
For Members of the Public in Ireland
Information on GSK medicines
Report a suspected side effect
Patient Information Leaflet
This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.
The following information leaflet is available:
Information for Patients (Patient Card)
Adverse events should be reported directly to the Health Products Regulatory Authority (HPRA) on their website: www.hpra.ie. Adverse events should also be reported to GlaxoSmithKline on 1800 244 255.
Volibris is a registered trademark of Gilead, used under licence by the GlaxoSmithKline Group of Companies.
NP-IE-AMB-WCNT-230001 Date of Preparation: September 2023
To report an adverse event or any other general enquiry.
© 2022 to 2023 GlaxoSmithKline plc. All rights reserved. Registered in Ireland: GlaxoSmithKline (Ireland) Limited, a private company limited by shares, and a member of the GlaxoSmithKline group of companies. Registered in Ireland with Company Number 15513. Registered office: 12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland. PM-IE-NA-WCNT-220017 Date of preparation: November 2022
This browser is not supported and will result in the website not being optimally presented. You are recommended to use an alternate browser such as Chrome, Opera or FireFox